H Kesteloot. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralAniline CompoundsAnti-Arrhythmia Agents/therapeutic useAtrial Fibrillation/drug therapyAtrial Flutter/drug therapyCardiac Complexes, Premature/drug therapyCardiac Complexes, Premature/physiopathologyDiethylaminesHeadache/chemically inducedHeart Atria/physiopathologyHeart Ventricles/physiopathologyHumansIndans/administration & dosageIndans/adverse effectsIndans/therapeutic useIndenes/therapeutic useInjections, IntravenousTachycardia/drug therapyTachycardia/physiopathologyTremor/chemically inducedVertigo/chemically inducedWolff-Parkinson-White Syndrome/drug therapyWolff-Parkinson-White Syndrome/physiopathology
Substances: See more » Aniline CompoundsAnti-Arrhythmia AgentsDiethylaminesIndansIndenes
Year: 1974 PMID: 4138773
Source DB: PubMed Journal: Acta Cardiol ISSN: 0001-5385 Impact factor: 1.718